Risks of non-ovarian cancers in women with borderline ovarian tumor: a national cohort study in Sweden.

This Swedish population-based study demonstrated an increased risk of multiple malignancies including lung and pancreatic cancers beyond the first year of diagnosis in patients with borderline ovarian tumors (BOTs), suggesting a potential shared etiology.